Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2011 2
2012 2
2013 1
2014 1
2016 1
2017 3
2018 1
2020 1
2021 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Coenzyme A fuels T cell anti-tumor immunity.
St Paul M, Saibil SD, Han S, Israni-Winger K, Lien SC, Laister RC, Sayad A, Penny S, Amaria RN, Haydu LE, Garcia-Batres CR, Kates M, Mulder DT, Robert-Tissot C, Gold MJ, Tran CW, Elford AR, Nguyen LT, Pugh TJ, Pinto DM, Wargo JA, Ohashi PS. St Paul M, et al. Among authors: laister rc. Cell Metab. 2021 Dec 7;33(12):2415-2427.e6. doi: 10.1016/j.cmet.2021.11.010. Cell Metab. 2021. PMID: 34879240 Free article.
Targeting tumour-associated macrophages in hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels.
Bahlmann LC, Xue C, Chin AA, Skirzynska A, Lu J, Thériault B, Uehling D, Yerofeyeva Y, Peters R, Liu K, Chen J, Martel AL, Yaffe M, Al-Awar R, Goswami RS, Ylanko J, Andrews DW, Kuruvilla J, Laister RC, Shoichet MS. Bahlmann LC, et al. Among authors: laister rc. Biomaterials. 2023 Jun;297:122121. doi: 10.1016/j.biomaterials.2023.122121. Epub 2023 Apr 9. Biomaterials. 2023. PMID: 37075613
An evaluation of pembrolizumab for classical Hodgkin lymphoma.
Manji F, Laister RC, Kuruvilla J. Manji F, et al. Among authors: laister rc. Expert Rev Hematol. 2022 Apr;15(4):285-293. doi: 10.1080/17474086.2022.2061947. Epub 2022 Apr 11. Expert Rev Hematol. 2022. PMID: 35389317 Review.
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review.
Oppegaard KR, Armstrong TS, Anguera JA, Kober KM, Kelly DL, Laister RC, Saligan LN, Ayala AP, Kuruvilla J, Alm MW, Byker WH, Miaskowski C, Mayo SJ. Oppegaard KR, et al. Among authors: laister rc. Crit Rev Oncol Hematol. 2022 Dec;180:103822. doi: 10.1016/j.critrevonc.2022.103822. Epub 2022 Sep 21. Crit Rev Oncol Hematol. 2022. PMID: 36152911 Review.
The SMX DNA Repair Tri-nuclease.
Wyatt HD, Laister RC, Martin SR, Arrowsmith CH, West SC. Wyatt HD, et al. Among authors: laister rc. Mol Cell. 2017 Mar 2;65(5):848-860.e11. doi: 10.1016/j.molcel.2017.01.031. Mol Cell. 2017. PMID: 28257701 Free PMC article.
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy.
St Paul M, Saibil SD, Kates M, Han S, Lien SC, Laister RC, Hezaveh K, Kloetgen A, Penny S, Guo T, Garcia-Batres C, Smith LK, Chung DC, Elford AR, Sayad A, Pinto D, Mak TW, Hirano N, McGaha T, Ohashi PS. St Paul M, et al. Among authors: laister rc. Cell Rep Med. 2024 Mar 19;5(3):101465. doi: 10.1016/j.xcrm.2024.101465. Epub 2024 Mar 8. Cell Rep Med. 2024. PMID: 38460518 Free PMC article.
Analysis of the Circulating Metabolome of Patients with Cutaneous, Mucosal and Uveal Melanoma Reveals Distinct Metabolic Profiles with Implications for Response to Immunotherapy.
Vilbert M, Koch EC, Rose AAN, Laister RC, Gray D, Sotov V, Penny S, Spreafico A, Pinto DM, Butler MO, Saibil SD. Vilbert M, et al. Among authors: laister rc. Cancers (Basel). 2023 Jul 21;15(14):3708. doi: 10.3390/cancers15143708. Cancers (Basel). 2023. PMID: 37509369 Free PMC article.
20 results